- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-43-0032814

Midlife Biosciences Private Limited
About Midlife Biosciences Private Limited
Data last updated:
Midlife Biosciences Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2006PTC032662. Its GSTIN is 09AAFCM0422J1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Manoj Kumar Singh and Vinod Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 37K. Rampuram Saryu Prasad Memorial School Shyam Nagar, Kanpur, Uttar Pradesh, India – 208013.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.68 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹4.24 Lakh (net margin -5.9%) and EBITDA of -₹4.24 Lakh (EBITDA margin -5.9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
Midlife Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0032814). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Midlife Biosciences
Contact details
Midlife Biosciences Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address37K. Rampuram Saryu Prasad Memorial School Shyam Nagar, Kanpur, Uttar Pradesh, India – 208013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Midlife Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Midlife Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Midlife Biosciences Private Limited, buy the company report.
Financials of Midlife Biosciences Private Limited
FY 2025 filings availableMidlife Biosciences Private Limited reported revenue of ₹71.68 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.9% | ||||
| Net Profit Margin | -5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Midlife Biosciences Private Limited, buy the company report.
Board of directors of Midlife Biosciences Private Limited
Midlife Biosciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Singh | Director | 16 May 2007 | 19 Years 5 Months | Current |
| Vinod Kumar Singh | Director | 22 Dec 2006 | 19 Years 10 Months | Current |
Peer comparison
Midlife Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Styris Pharma Private Limited | ₹71.98 Lakh (FY 2021) | -32.0% | Telangana, India | |||
| Newmark Biosciences Private Limited | ₹71.96 Lakh (FY 2024) | -13.0% | Bareilly, Uttar Pradesh, India | |||
| Midlife Biosciences Private Limitedthis company | ₹71.68 Lakh (FY 2025) | -₹4.24 Lakh | -5.9% | 8.0% | Kanpur, Uttar Pradesh, India | |
| Dorris Pharmaceuticals Private Limited | ₹71.6 Lakh (FY 2024) | -9.0% | Delhi, India | |||
| San Smith Pharma Private Limited | ₹71.18 Lakh (FY 2025) | -28.0% | Kurukshetra, Haryana, India |
To see the full peer comparison of Midlife Biosciences Private Limited, buy the company report.
Auditor
Midlife Biosciences Private Limited is audited by ROHIT NARANG & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHIT NARANG & ASSOCIATES | FY 2020 | 005321C |
Shareholding
The shareholding of Midlife Biosciences Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Midlife Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Midlife Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Midlife Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Midlife Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCM0422J1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Midlife Biosciences Private Limited, buy the company report.
Recent activity
Midlife Biosciences Private Limited has 8 board changes on record since 2006: 5 appointments and 3 cessations. The latest: Amit Das ceased to be Director on 28 Feb 2011.
Frequently asked questions
Midlife Biosciences is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 December 2006 (20+ years old) and is registered under CIN U24232UP2006PTC032662.
Midlife Biosciences has 2 current directors:
- Manoj Kumar Singh - Director
- Vinod Kumar Singh - Director
The latest financial statements of Midlife Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Midlife Biosciences is 09AAFCM0422J1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Midlife Biosciences is U24232UP2006PTC032662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Midlife Biosciences was incorporated on 22 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Midlife Biosciences by revenue are Styris Pharma Private Limited, Newmark Biosciences Private Limited, Dorris Pharmaceuticals Private Limited, San Smith Pharma Private Limited, all in the Pharma industry (Biosciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Amit Das ceased to be Director on 28 Feb 2011. Dharmendra Kumar ceased to be Director on 23 Nov 2007. Maya Pati Shukla ceased to be Director on 23 Nov 2007. Midlife Biosciences has 8 board changes on record in total.
Yes, Midlife Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0032814).
The registered office of Midlife Biosciences is at 37K. Rampuram Saryu Prasad Memorial School Shyam Nagar, Kanpur, Uttar Pradesh, India – 208013.
Midlife Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

